INDIVIOR PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 725.50 GBX | -0.34% |
|
+1.04% | -38.78% |
| 09-05 | Transcript : Indivior PLC Presents at Morgan Stanley 22nd Annual Global Healthcare Conference, Sep-05-2024 10:45 AM | |
| 09-04 | Indivior reports "disappointing" results for study with Aelis Farma | AN |
Main competitors
| Revenues ($) (Y-1) | Net margin (Y-1) | Operating Margin (Y-1) | ROE (Y-1) | ROA (Y-1) | Leverage (Debt/EBITDA) (Y-1) | ||
|---|---|---|---|---|---|---|---|
| 1.09B | +0.18% | +24.61% | +874.51% | - | -0.27x | ||
| 23.34B | +13.45% | +17.19% | +14.03% | +7.61% | 1.35x | ||
| 3.12B | +18.36% | +21.67% | +10.20% | +9.89% | -3.42x | ||
| 1.4B | +7.67% | +3.05% | +6.92% | +5.15% | -0.95x | ||
| 268M | -9.56% | -10.45% | -10.96% | -4.74% | 4.35x | ||
| 346M | +14.17% | +11.00% | +6.89% | +4.08% | 2.85x | ||
| 1.7B | +5.73% | - | +6.02% | +3.55% | - | ||
| 207M | +16.36% | +18.84% | +14.77% | +12.61% | - | ||
| 608M | +0.22% | +20.59% | - | - | - | ||
| 257M | +27.46% | +30.65% | +13.23% | +9.94% | - | ||
| 118M | -38.63% | -30.91% | -84.68% | - | 0.02x | ||
| 533M | +14.77% | +5.31% | +5.40% | +2.55% | -2.56x | ||
| 591M | - | +5.52% | +4.85% | +3.16% | - | ||
| 3.74M | - | -659.58% | -21.93% | - | 2.36x | ||
| 582M | +3.21% | +6.54% | +2.64% | +1.43% | 5.16x | ||
| 73.82M | +16.96% | +18.54% | +5.47% | +2.91% | - | ||
| Average | 2.14B | +6.45% | -34.49% | +56.49% | +4.85% | 0.89x | |
| Weighted average by Cap. | 15.84B | +11.66% | +9.06% | +19.13% | +6.83% | 0.87x |
- Stock Market
- Equities
- INDV Stock
- Sector Indivior PLC
- Financial comparisons
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition